glp 1 vs glp 1 agonist Comparison of GLP-1 receptor agonists and DPP-4 inhibitors Research shows GLP-1 receptor agonist
Description
The Institute for Safe Medication Practices Canada (ISMP Canada) is an independent national not-for-profit organization committed to the advancement of medication safety in all healthcare settings
2010, doi: 10.1111/j.2040-1124.2010.00022.x
As a GLP-1 receptor agonist, it regulates appetite and improves blood sugar control, making it suitable for those with obesity or related health issues
The language matters
Nationwide retrospective studies utilizing register data from Sweden and Denmark (20132021) and the UK CPRD (20072020) have revealed consistent findings, indicating that GLP-1 RAs are not associated with an elevated risk of suicidality relative to DPP-4 or SGLT-2 inhibitors [77,78]
However, only about 3% had at least one claim in 2022
